BACKGROUND/ PURPOSE:Infants requiringextracorporeal membrane oxygenation (ECMO) have the highest rates of protein catabolism ever reported. Recent investigations have found that such extreme protein breakdown is refractory to conventional nutritional management. In this pilot study, the authors sought to use the anabolic hormone insulin to reduce the profound protein degradation in this cohort. METHODS:Four parenterally fed infants on ECMO were enrolled in a prospective, randomized, crossover trial. Subjects were administered an insulin infusion using a 4-hour hyperinsulinemic euglycemic clamp followed by a control saline infusion on consecutive days in random order. Whole-body protein flux and breakdown were quantified using a primed continuous infusion of the stable isotope L-[1-13C]leucine. Statistical analyses were performed using paired t tests. RESULTS:Serum insulin levels were increased 15-fold during the insulin clamp compared with the saline control (407 +/- 103 v 26 +/- 12 microU/mL; P <.05). During the insulin infusion, infants had decreased rates of total leucine flux (214 +/- 25 v 298 +/- 38 micromol/kg/h; P <.05) and leucine flux derived from protein breakdown (156 +/- 40 v 227 +/- 54 micromol/kg/h; P <.05) when compared with saline control. Overall, insulin administration produced a 32% reduction in protein breakdown (P <.05). CONCLUSIONS: In this pilot study, the anabolic hormone insulin markedly reduced protein breakdown in critically ill infants on ECMO. Because elevated protein breakdown correlates with mortality and morbidity, the administration of intravenous insulin may ultimately have broad applicability to the metabolic management of critically ill infants.
RCT Entities:
BACKGROUND/ PURPOSE:Infants requiring extracorporeal membrane oxygenation (ECMO) have the highest rates of protein catabolism ever reported. Recent investigations have found that such extreme protein breakdown is refractory to conventional nutritional management. In this pilot study, the authors sought to use the anabolic hormone insulin to reduce the profound protein degradation in this cohort. METHODS: Four parenterally fed infants on ECMO were enrolled in a prospective, randomized, crossover trial. Subjects were administered an insulin infusion using a 4-hour hyperinsulinemic euglycemic clamp followed by a control saline infusion on consecutive days in random order. Whole-body protein flux and breakdown were quantified using a primed continuous infusion of the stable isotope L-[1-13C]leucine. Statistical analyses were performed using paired t tests. RESULTS: Serum insulin levels were increased 15-fold during the insulin clamp compared with the saline control (407 +/- 103 v 26 +/- 12 microU/mL; P <.05). During the insulin infusion, infants had decreased rates of total leucine flux (214 +/- 25 v 298 +/- 38 micromol/kg/h; P <.05) and leucine flux derived from protein breakdown (156 +/- 40 v 227 +/- 54 micromol/kg/h; P <.05) when compared with saline control. Overall, insulin administration produced a 32% reduction in protein breakdown (P <.05). CONCLUSIONS: In this pilot study, the anabolic hormone insulin markedly reduced protein breakdown in critically ill infants on ECMO. Because elevated protein breakdown correlates with mortality and morbidity, the administration of intravenous insulin may ultimately have broad applicability to the metabolic management of critically ill infants.
Authors: Y Sakurai; A Aarsland; D N Herndon; D L Chinkes; E Pierre; T T Nguyen; B W Patterson; R R Wolfe Journal: Ann Surg Date: 1995-09 Impact factor: 12.969
Authors: P Tessari; S Inchiostro; G Biolo; R Trevisan; G Fantin; M C Marescotti; E Iori; A Tiengo; G Crepaldi Journal: J Clin Invest Date: 1987-04 Impact factor: 14.808
Authors: Samer W El-Kadi; Agus Suryawan; Maria C Gazzaneo; Neeraj Srivastava; Renán A Orellana; Hanh V Nguyen; Gerald E Lobley; Teresa A Davis Journal: Am J Physiol Endocrinol Metab Date: 2012-01-03 Impact factor: 4.310
Authors: Michael S D Agus; Patrick J Javid; Hannah G Piper; David Wypij; Christopher P Duggan; Daniel P Ryan; Tom Jaksic Journal: Ann Surg Date: 2006-10 Impact factor: 12.969
Authors: Garry M Steil; Jamin Alexander; Alexandra Papas; Langer Monica; Biren P Modi; Hannah Piper; Tom Jaksic; Rebecca Gottlieb; Michael S D Agus Journal: J Diabetes Sci Technol Date: 2011-01-01
Authors: Masaki Kajimoto; Colleen M O'Kelly Priddy; Dolena R Ledee; Chun Xu; Nancy Isern; Aaron K Olson; Michael A Portman Journal: J Mol Cell Cardiol Date: 2013-05-30 Impact factor: 5.000
Authors: Maria M J van der Vorst; Enno Wildschut; Robbert J Houmes; Saskia J Gischler; Joana E Kist-van Holthe; Jacobus Burggraaf; Albert J van der Heijden; Dick Tibboel Journal: Crit Care Date: 2006 Impact factor: 9.097